This job has expired

Group Leader Discovery Pharmacology

Employer
Nerviano Medical Sciences Srl
Location
Italy (IT)
Salary
Competitive
Closing date
Dec 2, 2022

View more

Discipline
Life Sciences, Biology
Position Type
Full Time
Job Type
Group Leader/Principal Investigator
Organization Type
All Industry
You need to sign in or create an account to save a job.

Group Leader, Discovery Pharmacology

Nerviano Medical Sciences Srl (NMS) is seeking an experienced and highly motivated   senior scientist with a proven and outstanding track record in the area of cancer cell biology, as applied to innovative drug discovery and development, to lead the targeted biology group within the Discovery Pharmacology Department.  You will lead a group of talented and experienced scientists and technical staff in the identification and validation of potential new therapeutic approaches and in the advancement of  highly innovative drug candidates from cellular proof of concept to in vivo stages, together with identification of clinically applicable biomarkers, to generate high value clinical candidates.

Reporting to the Head of Discovery Pharmacology, you will work in a multidisciplinary team of highly skilled scientists within a science-driven, team-oriented, and multi-disciplinary biotech environment covering all stages of drug discovery and clinical development.  You will work in a state-of-the-art cell biology laboratory and lead the development of projects in close collaboration with chemistry and biotechnology functions to provide much needed targeted, innovative and effective therapies to the patient community.

About NMS

As a pioneering oncological R&D company, NMS has always set benchmarks in therapies for oncology, committed to improve patient health through discovering, developing and delivering lifesaving medicines. The history of NMS can be back tracked to 1965, when Farmitalia SpA opened a research center in Nerviano, close to Milan, Italy. Over the past 50 years, the Nerviano R&D site has played a role in the fight against cancer, starting from the discovery and development of anthracyclines drugs such as doxorubicin, which are among the most successful class of anti-cancer agents discovered to date and still widely used in treating multiple cancer types in combination regimens. Through different stages of evolution, including being the reference R&D Oncology site of the global Pharmacia company for about 10 years, the center became today’s stand-alone organization known as Nerviano Medical Sciences (NMS). Building on its strong scientific competence and IP position, the most recent achievements from NMS’s continuous research and innovation are the out-licensed products in the current portfolio: encorafenib currently commercialized by Pfizer as Braftovi®, for which NMS outlicensed IP rights to Novartis/Array Biopharma, entrectinib outlicensed to Ignyta and now commercialized by Roche as Rozlytrek®, one of the first targeted therapies with agnostic label in a molecularly defined patient population, milciclib outlicensed to Tiziana Life Sciences, onvansertib to Trovagene (now Cardiff Oncology) as well as NMS-293 a second generation PARP1 selective inhibitor on which NMS has recently signed a collaboration agreement with outlicensing option with Merck KGaA.

Today NMS is the R&D core business of the holding company NMS Group, which includes a total of about 430 employees. The outstanding discovery and clinical development team of about 130 researchers at NMS is focused on inventing and developing First-in-Class/Best-in-Class small molecule therapies, with more than a dozen anti-cancer projects in its robust pipeline, including five assets generated by its internal research currently in clinical development. NMS and the other Group affiliates Accelera and NerPharma together cover all the drug discovery and development process, from target identification & validation to preclinical and clinical development.

What’s in it for you?

NMS’ long history, its experienced team and the results of its research are recognized by peers and partners all over the globe. It is a unique opportunity to join a rapidly growing and evolving company at a critical inflexion point.

You will work within cross-functional teams of scientists to apply your knowledge and you will be expected to make a strong impact on the preclinical and clinical success of the projects.

Key Responsibilities:

  • Supervise and coordinate the work of a well-balanced group of high-profile young scientists and experienced professionals dedicated to innovative targets identification, in vitro mechanism and proof of concept, efficacy and therapeutic context determination and PK/PD driven development of innovative drugs to support the timely advancement of the NMS oncological Pipeline. Drive scientific expertise, problem-solving and innovation in key areas of biological interest, such as novel means of further exploiting NMS kinase platform, novel opportunities in the field of DNA Damage Repair, a key area in cancer drug development which NMS is committed to leveraging to the maximum of its potential and novel approaches to molecular target inhibition in areas of high medical need in Oncology Act as Project Leader for specific projects to guide the advancement of preclinical discovery programs Develop talents and promote growth of collaborators Establish yourself as a key innovator at NMS, also having accountability for establishing international research contacts and collaborations with academic/biotech partners.

Qualifications & Experience:

  • PhD in Biology or equivalent. Demonstrated track record and hands on expertise in target validation, identification and characterization of innovative novel small molecule drugs and ability to guide their subsequent mechanism-driven transition to clinical testing in the field of Oncology. Previous experience in people management as Group Leader or Project Leader, with at least 5 years in an R&D biotech/Pharma setting Strong networking potential, including direct access to KOLs in oncological R&D Biotech/Pharma and/or academic field Ability to multitask, work well under pressure to meet timelines and be self-motivated. Excellent organizational and communication skills, flexibility and a demonstrated ability to interact effectively within a multidisciplinary team.
You need to sign in or create an account to save a job.

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert